Insider · CIK 0001883766
Eva Renee Barnett
Files at IMVT (Immunovant, Inc.). First filing Oct 11, 2023, latest Apr 17, 2025.
In brief
Eva Renee Barnett files SEC Form 4 as CFO at IMVT (Immunovant, Inc.). Since Oct 11, 2023, Eva Renee Barnett has reported 0 open-market buys worth $0 and 12 open-market sells worth $1.3M, the latest filed on Apr 17, 2025.
A track record needs three past buys with six months of prices behind them; Eva Renee Barnett has 0, so none is measured yet.
The newest scored trade: sold $45k of IMVT on Apr 16, 2025, filed Apr 17, 2025, scored 43 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Immunovant, Inc. | $45k 2,993 shares | -1% | +12% from low-53% from high | |
| 48Moderate | Immunovant, Inc. | $144k 11,063 shares | -3% | +12% from low-53% from high | |
| 44Moderate | Immunovant, Inc. | $59k 2,814 shares | -1% | - | |
| 44Moderate | Immunovant, Inc. | $55k 2,298 shares | -1% | - | |
| 47Moderate | Immunovant, Inc. | $99k 4,105 shares | -1% | - | |
| 47Moderate | Immunovant, Inc. | $106k 4,174 shares | -1% | - | |
| 47Moderate | Immunovant, Inc. | $94k 3,271 shares | -1% | - | |
| 48Moderate | Immunovant, Inc. | $153k 5,162 shares | -2% | - | |
| 47Moderate | Immunovant, Inc. | $106k 2,930 shares | -1% | +153% from low-19% from high | |
| 48Moderate | Immunovant, Inc. | $147k 3,515 shares | -1% | +202% from low-3% from high | |
| 48Moderate | Immunovant, Inc. | $133k 4,055 shares | -1% | +157% from low-18% from high | |
| 41Moderate | Immunovant, Inc. | $168k 4,557 shares | -1% | +305% from low-7% from high |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 16, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,993 | $14.89 | $45k | 396,774 | Apr 17, 2025 |
| Apr 9, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -7,013 | $12.99 | $91k | 403,817 | Apr 11, 2025 |
| Apr 9, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -4,050 | $12.99 | $53k | 399,767 | Apr 11, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +88,878 | $0.00 | $0 | 410,830 | Apr 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +125,180 | $0.00 | $0 | 125,180 | Apr 3, 2025 |
| Feb 19, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,814 | $20.86 | $59k | 321,952 | Feb 21, 2025 |
| Jan 15, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,189 | $23.81 | $52k | 324,875 | Jan 17, 2025 |
| Jan 15, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -109 | $24.19 | $2,637 | 324,766 | Jan 17, 2025 |
| Jan 8, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -4,105 | $24.10 | $99k | 327,064 | Jan 10, 2025 |
| Nov 20, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -4,174 | $25.45 | $106k | 331,169 | Nov 22, 2024 |
| Oct 16, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -3,271 | $28.79 | $94k | 335,343 | Oct 18, 2024 |
| Oct 9, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -5,162 | $29.56 | $153k | 338,614 | Oct 11, 2024 |
| Feb 22, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,930 | $36.15 | $106k | 320,420 | Feb 23, 2024 |
| Jan 11, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,681 | $41.64 | $112k | 324,184 | Jan 12, 2024 |
| Jan 11, 2024 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -834 | $42.43 | $35k | 323,350 | Jan 12, 2024 |
| Nov 22, 2023 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -3,901 | $32.75 | $128k | 327,019 | Nov 24, 2023 |
| Nov 22, 2023 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -154 | $33.52 | $5,162 | 326,865 | Nov 24, 2023 |
| Oct 10, 2023 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -4,557 | $36.92 | $168k | 330,920 | Oct 11, 2023 |
Questions about Eva Renee Barnett
Answered from the filings on this page, as of the latest one.
Is Eva Renee Barnett buying or selling?
Not in the last 12 months. Eva Renee Barnett's latest open-market trade on SEC Form 4 was sold $45k of IMVT on Apr 16, 2025.
How did Eva Renee Barnett's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eva Renee Barnett has 0.
Where does Eva Renee Barnett file Form 4?
Eva Renee Barnett has filed Form 4 at IMVT (Immunovant, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.